Reduction in Nuclear Size by DHRS7 in Prostate Cancer Cells and by Estradiol Propionate in DHRS7-Depleted Cells.

Autor: Rizzotto, Andrea¹ (AUTHOR) andrea.rizzotto88@gmail.com, Tollis, Sylvain² (AUTHOR) sylvain.tollis@uef.fi, Pham, Nhan T.³ (AUTHOR) nhan.pham@ed.ac.uk, Zheng, Yijing³ (AUTHOR) yzheng10@gmail.com, Abad, Maria Alba⁴ (AUTHOR) mabadfe@exseed.ed.ac.uk, Wildenhain, Jan³ (AUTHOR) jan.wildenhain@gmail.com, Jeyaprakash, A. Arockia^1,4,5 (AUTHOR) jeyaprakash.arulanandam@ed.ac.uk, Auer, Manfred^3,6 (AUTHOR) manfred.auer@ed.ac.uk, Tyers, Mike^7,8 (AUTHOR) mike.tyers@sickkids.ca, Schirmer, Eric C.¹ (AUTHOR) e.schirmer@ed.ac.uk

Publikováno v: Cells (2073-4409). Jan2024, Vol. 13 Issue 1, p57. 13p.

DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer

Autor: Sheng Tang, Zhenyu Zhao, Yuhang Wang, Mariya M. El Akkawi, Zhennan Tan, Dongbin Liu, Guoxiong Chen, Hu Liu

Publikováno v: Frontiers in Genetics, Vol 13 (2022)

Renal clear cell carcinoma (KIRC) is one malignancy whose development and prognosis have been associated with aberrant DHRS7 expression. However, the catalytic activity and pathophysiology of KIRC are poorly understood, and no sensitive tumor biomark

Externí odkaz: https://doaj.org/article/a9edd1b853904284990988e1e590a74d

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Reduction in Nuclear Size by DHRS7 in Prostate Cancer Cells and by Estradiol Propionate in DHRS7-Depleted Cells.

Autor: Rizzotto A; The Institute of Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK., Tollis S; Institute of Biomedicine, University of Eastern Finland, 70210 Kuopio, Finland., Pham NT; The Institute of Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Edinburgh EH9 3BF, UK., Zheng Y; The Institute of Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Edinburgh EH9 3BF, UK., Abad MA; Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK., Wildenhain J; The Institute of Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Edinburgh EH9 3BF, UK., Jeyaprakash AA; The Institute of Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK.; Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK.; Gene Center and Department of Biochemistry, LMU-München, 81377 Munich, Germany., Auer M; The Institute of Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Edinburgh EH9 3BF, UK.; Xenobe Research Institute, P.O. Box 3052, San Diego, CA 92163-1052, USA., Tyers M; Program in Molecular Medicine, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada., Schirmer EC; The Institute of Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK.

Publikováno v: Cells [Cells] 2023 Dec 27; Vol. 13 (1). Date of Electronic Publication: 2023 Dec 27.

The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples

Autor: Odermatt, Simon Stücheli, Selene Araya, Caner Ercan, Seraina O. Moser, John Gallon, Paul Jenö, Salvatore Piscuoglio, Luigi Terracciano, Alex

Publikováno v: Cancers; Volume 14; Issue 13; Pages: 3074

Prostate cancer (PCa), one of the most common malignancies in men, typically responds to initial treatment, but resistance to therapy often leads to metastases and death. The dehydrogenase/reductase 7 (DHRS7, SDR34C1) is an “orphan” enzyme withou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=multidiscipl::fca352853acb64ed34e12aec1ae4ac13